(Q37600865)

21 August 2017

1 reference

title

Plasmapheresis for neurological disorders (English)

1 reference

21 August 2017

3

Ralf Gold

1 reference

21 August 2017

Alexandra Schröder

1

1 reference

PubMed ID

19769448

21 August 2017

Ralf A Linker

series ordinal

2

1 reference

21 August 2017

1 September 2009

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

21 August 2017

1 reference

21 August 2017

9

1 reference

21 August 2017

9

1 reference

21 August 2017

1331-1339

1 reference

A case report of double-filtration plasmapheresis for the treatment of age-related macular degeneration

21 August 2017

1 reference

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.

21 January 2018

1 reference

Plasma exchange for severe optic neuritis: treatment of 10 patients

21 January 2018

1 reference

Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients

21 January 2018

1 reference

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

21 January 2018

1 reference

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

21 January 2018

1 reference

High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes

21 January 2018

1 reference

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

21 January 2018

1 reference

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

21 January 2018

1 reference

Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study.

21 January 2018

1 reference

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

21 January 2018

1 reference

Improving MS patient care

21 January 2018

1 reference

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

21 January 2018

1 reference

The immunopathology of multiple sclerosis: an overview

21 January 2018

1 reference

Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders

21 January 2018

1 reference

Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin

21 January 2018

1 reference

Lesion pathology predicts response to plasma exchange in secondary progressive MS.

21 January 2018

1 reference

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

Immunoadsorption patients with multiple sclerosis: an open-label pilot study

21 January 2018

1 reference

Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome

21 January 2018

1 reference

Successful outcome with aggressive treatment of acute haemorrhagic leukoencephalitis.

21 January 2018

1 reference

Acute hemorrhagic leukoencephalitis. A successful recovery.

21 January 2018

1 reference

Successful immune treatment for non-paraneoplastic limbic encephalitis

21 January 2018

1 reference

A case of paraneoplastic syndrome accompanied by two types of cancer

21 January 2018

1 reference

Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin.

21 January 2018

1 reference

Potassium channel antibodies in two patients with reversible limbic encephalitis

21 January 2018

1 reference

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

21 January 2018

1 reference

Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis

21 January 2018

1 reference

Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies

21 January 2018

1 reference

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

21 January 2018

1 reference

Treatment of thrombotic microangiopathies with plasma exchange

21 January 2018

1 reference

Systemic lupus erythematosus with organic brain syndrome: serial electroencephalograms accurately evaluate therapeutic efficacy

21 January 2018

1 reference

Immunoadsorption therapy for a child with Guillain-Barre syndrome subsequent to Mycoplasma infection: a case study.

21 January 2018

1 reference

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

21 January 2018

1 reference

Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

21 January 2018

1 reference

Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study

21 January 2018

1 reference

Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis

21 January 2018

1 reference

Current and future standards in treatment of myasthenia gravis

21 January 2018

1 reference

Successful immunoglobulin treatment in a patient with neuromyotonia.

21 January 2018

1 reference

Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial

21 January 2018

1 reference

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies

21 January 2018

1 reference

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

21 January 2018

1 reference

Intravenous immunoglobulin therapy for Miller Fisher syndrome

21 January 2018

1 reference

Intravenously Administered Immunoglobulin in the Treatment of Childhood Guillain-Barre Syndrome: A Randomized Trial

21 January 2018

1 reference

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.09.81

1 reference

release_golkx34jxbguddnzbzy7334fvi

21 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/golkx34jxbguddnzbzy7334fvi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

19769448

1 reference

PubMed ID

19769448